Bisindolylmaleimide IV, >=98% (TLC), solid

Code: b3306-1mg D2-231

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Bisindolylmaleimides (BIM) comprises a group of 11 compounds from BIM-I to BIM-XI. BIMs act as an inhibitor of protein kinase C (PKC). They are derive...


read more

Your Price
£86.30 1MG

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Bisindolylmaleimides (BIM) comprises a group of 11 compounds from BIM-I to BIM-XI. BIMs act as an inhibitor of protein kinase C (PKC). They are derived from staurosporine. BIM IX due to its proapoptotic functionality could be useful in targeting tumor proliferation.

assay≥98% (TLC)
biological sourcesynthetic (organic)
colordark red
formsolid
Gene Informationhuman ... CDK2(1017), EGFR(1956)rat ... Prkca(24680)
InChI keyDQYBRTASHMYDJG-UHFFFAOYSA-N
InChI1S/C20H13N3O2/c24-19-17(13-9-21-15-7-3-1-5-11(13)15)18(20(25)23-19)14-10-22-16-8-4-2-6-12(14)16/h1-10,21-22H,(H,23,24,25)
Quality Level200
SMILES stringO=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c4c[nH]c5ccccc45
solubilitymethanol: soluble, DMSO: soluble
storage temp.−20°C
Cas Number119139-23-0
This product has met the following criteria: